KraneShares MSCI All China Health Care ETF (KURE) Holdings
KURE holdings summary
as of Oct 24, 2026- Holdings
- 40 positions listed
- Top 10 weight
- 47.6% of net assets
- Effective holdings
- 24 equal-weight equivalent
- Largest holding
- 1801 8.18% Innovent Biologics Inc
- Annual turnover
- 31.6% of the portfolio traded
All KURE holdings
| # | Name | ||||||
|---|---|---|---|---|---|---|---|
| 1 | 1801 | Innovent Biologics Inc | Healthcare | 8.18% | $8.8M | — | — |
| 2 | 2269 | WuXi Biologics | Healthcare | 6.86% | $7.4M | — | — |
| 3 | 603259 | WuXi AppTec Co Ltd | Healthcare | 5.25% | $5.7M | — | — |
| 4 | 300760 | Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A | Healthcare | 5.19% | $5.6M | — | — |
| 5 | 600276 | Jiangsu Hengrui Medicine Co Ltd | Healthcare | 4.70% | $5.1M | — | — |
| 6 | 9926 | Akeso Inc | Healthcare | 4.14% | $4.5M | — | — |
| 7 | 1177 | Sino Biopharmaceutical Ltd | Healthcare | 3.58% | $3.9M | — | — |
| 8 | 1093 | CSPC Pharmaceutical Group Ltd | Healthcare | 3.46% | $3.7M | — | — |
| 9 | 2359 | WuXi AppTec Co Ltd H | Healthcare | 3.23% | $3.5M | — | — |
| 10 | 1548 | Genscript Biotech Corp | Healthcare | 3.03% | $3.3M | — | — |
| 11 | 3692 | Hansoh Pharmaceutical Group Co Ltd | Healthcare | 2.79% | $3.0M | — | — |
| 12 | 000538 | Yunnan Baiyao Group Co Ltd | Healthcare | 2.41% | $2.6M | — | — |
| 13 | 688271 | Shanghai United Imaging Healthcare Co. Ltd. A | Healthcare | 2.30% | $2.5M | — | — |
| 14 | 300015 | Aier Eye Hospital Group | Healthcare | 1.99% | $2.1M | — | — |
| 15 | 600436 | Zhangzhou Pientzehuang Pharmaceutical Co Ltd | Healthcare | 1.93% | $2.1M | — | — |
| 16 | 1530 | 3SBio Inc | Healthcare | 1.90% | $2.0M | — | — |
| 17 | 002422 | Sichuan Kelun Pharmaceutical Co Ltd | Healthcare | 1.85% | $2.0M | — | — |
| 18 | 688506 | Sichuan Biokin Pharmaceutical Co. Ltd. A | Healthcare | 1.80% | $1.9M | — | — |
| 19 | 300759 | Pharmaron Beijing Co Ltd | Healthcare | 1.48% | $1.6M | — | — |
| 20 | 1099 | Sinopharm Group Co Ltd | Healthcare | 1.44% | $1.6M | — | — |
| 21 | 002653 | Xizang Haisco Pharmaceutical Group Co Ltd | Healthcare | 1.39% | $1.5M | — | — |
| 22 | 2228 | XtalPi Holdings Limited | Healthcare | 1.21% | $1.3M | — | — |
| 23 | 2268 | WuXi XDC Cayman Inc | Healthcare | 1.20% | $1.3M | — | — |
| 24 | 600196 | Shanghai Fosun Pharmaceutical Group Co Ltd | Healthcare | 1.20% | $1.3M | — | — |
| 25 | 000963 | Huadong Medicine Co Ltd | Healthcare | 1.20% | $1.3M | — | — |
| 26 | 002821 | Asymchem Laboratories Tian Jin Co Ltd | Healthcare | 1.19% | $1.3M | — | — |
| 27 | 601607 | Shanghai Pharmaceuticals Holding Co Ltd | Healthcare | 1.17% | $1.3M | — | — |
| 28 | 300832 | Shenzhen New Industries Biomedical | Healthcare | 1.06% | $1.1M | — | — |
| 29 | 000999 | China Resources Sanjiu Medical & Pharmaceutical Co Ltd | Healthcare | 1.05% | $1.1M | — | — |
| 30 | 688578 | Shanghai Allist Pharmaceuticals Co. Ltd. A | Healthcare | 1.01% | $1.1M | — | — |
| 31 | 300765 | CSPC Innovation Pharmaceutical Co Ltd Class A | Consumer Defensive | 0.93% | $1.0M | — | — |
| 32 | 688331 | RemeGen Co. Ltd. A | Healthcare | 0.93% | $996,206.33 | — | — |
| 33 | 688617 | APT Medical Inc | Healthcare | 0.91% | $975,970.05 | — | — |
| 34 | 600085 | Beijing Tongrentang Co Ltd | Healthcare | 0.89% | $958,855.32 | — | — |
| 35 | 002294 | Shenzhen Salubris Pharmaceuticals Co Ltd | Healthcare | 0.84% | $902,236.79 | — | — |
| 36 | 0999 | Xiaocaiyuan Intl Hldg Ltd | Consumer Cyclical | 0.83% | $895,024.92 | — | — |
| 37 | 002252 | Shanghai RAAS Blood Products Co Ltd Class A | Healthcare | 0.83% | $890,934.61 | — | — |
| 38 | LEGN | Legend Biotech Corporation | Healthcare | 0.80% | $863,594.10 | $3.59B | — |
| 39 | 300896 | Imeik Technology Development Co | Healthcare | 0.76% | $816,770.79 | — | — |
| 40 | 300347 | Hangzhou Tigermed Consulting | Healthcare | 0.46% | $496,757.67 | — | — |
Weights as a percentage of net assets. Value held = weight × net assets ($107.6M). Market cap and P/E from each company's latest fundamentals (U.S.-listed stocks).
KURE sector breakdown
| Sector | Weight | Holdings | Largest |
|---|---|---|---|
| Healthcare | 85.6% | 38 | 1801, 2269, 603259 |
| Consumer Defensive | 0.9% | 1 | 300765 |
| Consumer Cyclical | 0.8% | 1 | 0999 |
Sum of the weights of the holdings in each sector.
KURE top industries
KURE overlap with other ETFs
| ETF | Fund | Overlap | Shared holdings | Expense ratio |
|---|---|---|---|---|
| VXUS | Vanguard Total International Stock ETF | 0.3% | 39 of 8,035 | 0.05% |
| VTI | Vanguard Total Stock Market ETF | 0.0% | 0 of 2,941 | 0.03% |
| SPY | SPDR S&P 500 ETF | 0.0% | 0 of 502 | 0.09% |
| QQQ | Invesco QQQ ETF | 0.0% | 0 of 101 | 0.17% |
| IWM | iShares Russell 2000 ETF | 0.0% | 0 of 1,962 | 0.19% |
| DIA | SPDR Dow Jones Industrial Average ETF | 0.0% | 0 of 30 | 0.16% |
Overlap = sum over shared holdings of the smaller of the two weights. 100% means identical portfolios.
About the KURE portfolio
KraneShares MSCI All China Health Care ETF holds 40 positions. The ten largest make up 47.6% of the fund, so it behaves like a portfolio of about 24 equally weighted positions. The biggest positions are Innovent Biologics Inc (8.18%), WuXi Biologics (6.86%), WuXi AppTec Co Ltd (5.25%), Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A (5.19%), Jiangsu Hengrui Medicine Co Ltd (4.70%).
By sector, Healthcare is 85.6%, Consumer Defensive is 0.9%, Consumer Cyclical is 0.8%. Holdings data is from the fund's latest portfolio as reported by EODHD on October 24, 2026; positions change as the fund rebalances.
Related: KURE chart, KURE performance, KURE dividends, KURE overview.
KURE holdings FAQ
How many holdings does KURE have?
KURE holds 40 positions as of October 24, 2026.
What are the top 10 holdings of KURE?
The ten largest holdings are Innovent Biologics Inc (8.18%), WuXi Biologics (6.86%), WuXi AppTec Co Ltd (5.25%), Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A (5.19%), Jiangsu Hengrui Medicine Co Ltd (4.70%), Akeso Inc (4.14%), Sino Biopharmaceutical Ltd (3.58%), CSPC Pharmaceutical Group Ltd (3.46%), WuXi AppTec Co Ltd H (3.23%), Genscript Biotech Corp (3.03%). Together they are 47.6% of the fund.
What percentage of KURE is Innovent Biologics Inc?
Innovent Biologics Inc is the largest holding at 8.18% of net assets, about $8.8M of the fund's $107.6M.
Which sector is the largest in KURE?
Healthcare is the largest sector at 85.6%, followed by Consumer Defensive (0.9%) and Consumer Cyclical (0.8%), based on the sectors of the individual holdings.
How concentrated is KURE?
The top 10 holdings are 47.6% of the fund. By the effective number of holdings (1 divided by the sum of squared weights) KURE behaves like a portfolio of about 24 equally weighted positions.